CDKN2A and Huntington disease: This increase (~5‐fold) was greater in magnitude than that of p16INK4a mRNA levels in HD NSCs (~1.7‐fold; Figure 4a) and accompanied by increased p16INK4a immunostaining (Figure 5c–e).